Do Multifocal or Multicentric pT1a Node-Negative HER2+ Breast Cancers Get Benefit From Systemic Treatment?

Breast Cancer Research and Treatment - Netherlands
doi 10.1007/s10549-019-05508-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

BCT Score Predicts Chemotherapy Benefit in Asian Patients With Hormone Receptor-Positive, HER2-negative, Lymph Node-Negative Breast Cancer

PLoS ONE
Multidisciplinary
2018English

Multicentric and Multifocal Versus Unifocal Breast Cancer: Is the Tumor-Node-Metastasis Classification Justified?

Breast Cancer Research and Treatment
Cancer ResearchOncology
2010English

CXCR4 Inhibitors Could Benefit to HER2 but Not to Triple-Negative Breast Cancer Patients

Oncogene
Cancer ResearchGeneticsMolecular Biology
2016English

Node Negative Breast Cancer.

BMJ
1990English

Benefit of Post Mastectomy Radiation Therapy (PMRT) in Node-Positive, HER2-Positive Patients With Breast Cancer Receiving Anti-Her2 Treatments

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2020English

Treatment of Advanced Hormone Receptor-Positive (HR+) HER2-negative Breast Cancer

Geburtshilfe und Frauenheilkunde
GynecologyMidwiferyMaternityObstetrics
2019English

The Preclinical Profile of the Duocarmycin-Based HER2-Targeting ADC SYD985 Predicts for Clinical Benefit in Low HER2-Expressing Breast Cancers

Molecular Cancer Therapeutics
Cancer ResearchOncology
2015English

Validation of Expression Patterns for Nine miRNAs in 204 Lymph-Node Negative Breast Cancers

PLoS ONE
Multidisciplinary
2012English

Choline as a Biomarker for Cell Proliferation: Do the Results From Proton MR Spectroscopy Show Difference Between HER2/neu Positive and Negative Breast Cancers?

International Journal of Cancer
Cancer ResearchOncology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy